News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT
Photo taken from Julien Mazière/Twitter
Oct 23, 2023, 15:35

Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT

Julien Mazières, Thoracic Oncology Specialist at Toulouse University Hospital, France, shared insights from the ALINA study from ESMO23 on X/Twitter:

“Another big hit ESMO 23. Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT. Impressive curves and HR 0.24. Immediate practice-changing trial.”

Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT

Source: Julien Mazières/Twitter.

alectinib ALINA study Benjamin J. Solomon cancer ESMO 2023 Julien Mazières OncoDaily Oncology Yi-Long Wu
Special Coverage
Blog
Jan 15, 2025, 16:21
Zainab Shinkafi-Bagudu: Excited to introduce "Learning Tuesday with Dr. ZSB"
Insight
Jan 15, 2025, 16:20
Liquid Biopsy Breakthrough - International Society of Liquid Biopsy
Blog
Jan 15, 2025, 16:16
Monica Bertagnolli is ending her tenure as NIH director
Blog
Jan 15, 2025, 16:15
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment
Insight
Jan 15, 2025, 16:13
Nihar Desai: A case of elevated white cell count in a 60-year-old male
Blog
Jan 15, 2025, 16:11
Megan-Claire Chase: Attending the Stand Up for Trans Georgians Rally
Positive
Jan 15, 2025, 15:57
William Pao: Breakthrough - The Quest for Life-Changing Medicines
Science
Jan 15, 2025, 15:32
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Insight
Jan 15, 2025, 15:27
Sylvester Study Highlights Global Trends in Lung Cancer Risk Factors: Tobacco, Pollution, and Asbestos
Insight
Jan 15, 2025, 15:20
Karen Knudsen: Clinical trials are the most advanced form of cancer care
Insight
Jan 15, 2025, 15:18
Triparna Sen: The SenLab retreat was an amazing success
Insight
Jan 15, 2025, 15:12
Senthil Kumar: First-Line Systemic Treatment for Advanced/Metastatic Salivary Gland Tumors